Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! Pharma Stock to Watch! FIIs & DIIs Bet Big as This Drugmaker Launches a New Eye Treatment in the US! FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market! Pushkar Shinde / Friday, February 14, 2025 0 187 Article rating: 3.3 FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market! Read more
114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent 114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent The company's net profit surged 81 per cent year-on-year (YoY) to Rs 276.4 crore, compared to Rs 152.9 crore in Q3 FY24. Manoj Reddy Sama / Thursday, February 13, 2025 0 266 Article rating: 3.8 Revenue grew by 9 per cent YoY to Rs 2,245.4 crore, up from Rs 2,052.9 crore in the corresponding quarter last year. Read more
Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24 Abhishek Wani / Wednesday, February 12, 2025 0 161 Article rating: 5.0 The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24 Read more
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent. Kiran Shroff / Tuesday, January 28, 2025 0 418 Article rating: 4.2 From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent. Read more
This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here This Pharma Stock Declines 4.86 per cent; Board Approves Rs 570 Crore Fundraise, Know the Stock Outlook Here The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis Abhishek Wani / Monday, January 27, 2025 0 220 Article rating: 3.3 The Board of Directors approved the issuance of commercial papers worth Rs 570 crore on a private placement basis Read more